Immunity to viruses

Immunological Reviews

Volumn 255, Issue 1, 2013, Pages 5-12

  Braciale, Thomas J ^a   Hahn, Young S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN M; INFLAMMASOME; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOPHAGY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INFLUENZA A; INFLUENZA A H7N9; INNATE IMMUNITY; MICROBIOME; NATURAL KILLER CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVIEW; ROTAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SIGNAL TRANSDUCTION; STRESS; STRUCTURAL HOMOLOGY; SYSTEMS BIOLOGY; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS PATHOGENESIS;

ADAPTIVE IMMUNITY; HUMANS; IMMUNITY, INNATE; VIRUS DISEASES; VIRUSES;

EID: 84881648617     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12109     Document Type: Review

References (50)

1. Brent L. The discovery of immunologic tolerance. Hum Immunol 1997;52:75-81.
2. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974;248:701-702.
3. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44:959-968.
4. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ. Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med 1986;163:903-921.
5. Wilkins C, Gale M Jr. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010;22:41-47.
6. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
7. Sato S, St-Pierre C, Bhaumik P, Nieminen J. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 2009;230:172-187.
8. Aoshi T, Koyama S, Kobiyama K, Akira S, Ishii KJ. Innate and adaptive immune responses to viral infection and vaccination. Curr Opin Virol 2011;1:226-232.
9. Gombault A, Baron L, Couillin I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol 2012;3:414.
10. Thomas PG, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009;30:566-575.
11. Anand PK, et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012;488:389-393.
12. Meissner TB, et al. NLR family member NLRC5 is a transcriptional regulator ofMHC class I genes. Proc Natl Acad Sci USA 2010;107:13794-13799.
13. Zuo J, Rowe M. Herpesviruses placating the unwilling host: manipulation of theMHC class II antigen presentation pathway. Viruses 2012;4:1335-1353.
14. Lupfer C, Kanneganti T-D. The expanding role of NLRs in antiviral immunity. Immunol Rev 2013;255:13-24.
15. Kotenko SV. IFN-lambdas. Curr Opin Immunol 2011;23:583-590.
16. Durbin RK, Kotenko SV, Durbin JE. Interferon induction and function at the mucosal surface. Immunol Rev 2013;255:25-39.
17. Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, Fukuhara S. Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 2001;166:2961-2969.
18. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009;43:67-93.
19. Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009;5:527-549.
20. Perot BP, Ingersoll MA, Albert ML. The impact of macroauthophagy on CD8+ T-cell-mediated antiviral immunity. Immunol Rev 2013;255:40-56.
21. Lambrecht BN, Neyt K. The role of lung dendritic cell subsets in immunity to respiratory viruses. Immunol Rev 2013;255:57-67.
22. Rudd BD, et al. Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol 2007;20:531-540.
23. Iborra S, et al. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest 2012;12:1628-1643.
24. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 2008;8:259-268.
25. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
26. Golden-Mason L, Rosen HR. Natural killer cells: multi-faceted players with key roles in hepatitis C immunity. Immunol Rev 2013;255:68-81.
27. Paust S, Senman B, von Andrian UH. Adaptive immune responses mediated by natural killer cells. Immunol Rev 2010;235:286-296.
28. Baumgarth N. How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth. Immunol Rev 2013;255:82-94.
29. Haury M, Sundblad A, Grandien A, Barreau C, Coutinho A, Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 1997;27:1557-1563.
30. Janeway CA, Paul WE. The specificity of cellular immune responses in guinea pigs. III. The precision of antigen recognition by T lymphocytes. J Exp Med 1976;144:1641-1656.
31. Yang HY, Dundon PL, Nahill SR, Welsh RM. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 1989;142:1710-1718.
32. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 1994;179:1933-1943.
33. Su L, Davis MM. Antiviral memory phenotype T cells in unexposed adults. Immunol Rev 2013;255:95-109.
34. Moseman EA, MvGavern DB. The great balancing act: regulation and fate of antiviral T-cell interactions. Immunol Rev 2013;255:110-124.
35. McGavern DB, Kang SS. Illuminating viral infections in the nervous system. Nat Rev Immunol 2011;11:318-329.
36. Azar GA, Lemaitre F, Robey EA, Bousso P. Subcellular dynamics of T cell immunological synapses and kinapses in lymph nodes. Proc Natl Acad Sci USA 2010;107:3675-3680.
37. Wortzman ME, Clouthier DL, McPherson AJ, Lin GHY, Watts TH. The contextual role of TNFR family members in CD8+ T-cell control of viral infections. Immunol Rev 2013;255:125-148.
38. Strutt TM, McKinstry KK, Marshall NB, Vong AM, Dutton RW, Swain SL. Multipronged CFD4+ T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol Rev 2013;255:149-164.
39. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, Lefrancois L. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 2004;20:551-562.
40. Shin H, Iwasaki A. Tissue-resident memory T cells. Immunol Rev 2013;255:165-181.
41. Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunol Rev 2013;255:182-196.
42. Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev 2012;245:227-238.
43. Getts DR, Chastain EML, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev 2013;255:197-209.
44. Goh C, Narayanan S, Hahn YS. Myeloid derived suppressor cells: the Dark Knight or the Joker in viral infections? Immunol Rev 2013;255:210-221.
45. Wilks J, Beilinson H, Golovkina TV. Dual role of commensal bacteria in viral infections. Immunol Rev 2013;255:222-229.
46. Ichinohe T, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011;108:5354-5359.
47. Abt MC, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012;37:158-170.
48. Graham BS. Advances in antiviral vaccine development. Immunol Rev 2013;255:230-242.
49. Pulendran B, Oh JZ, Nakaya H, Ravindran R, Kazmin DA. Immunity to viruses: learning from successful human vaccines. Immunol Rev 2013;255:243-255.
50. Menachery VD, Baric RS. Bugs in the system. Immunol Rev 2013;255:256-274.